These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24886864)

  • 1. Coefficient of glucose variation is independently associated with mortality in critically ill patients receiving intravenous insulin.
    Lanspa MJ; Dickerson J; Morris AH; Orme JF; Holmen J; Hirshberg EL
    Crit Care; 2014 Apr; 18(2):R86. PubMed ID: 24886864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A replicable method for blood glucose control in critically Ill patients.
    Morris AH; Orme J; Truwit JD; Steingrub J; Grissom C; Lee KH; Li GL; Thompson BT; Brower R; Tidswell M; Bernard GR; Sorenson D; Sward K; Zheng H; Schoenfeld D; Warner H
    Crit Care Med; 2008 Jun; 36(6):1787-95. PubMed ID: 18520641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percentage of Time in Range 70 to 139 mg/dL Is Associated With Reduced Mortality Among Critically Ill Patients Receiving IV Insulin Infusion.
    Lanspa MJ; Krinsley JS; Hersh AM; Wilson EL; Holmen JR; Orme JF; Morris AH; Hirshberg EL
    Chest; 2019 Nov; 156(5):878-886. PubMed ID: 31201784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate glucose control is associated with increased mortality compared with tight glucose control in critically ill patients without diabetes.
    Lanspa MJ; Hirshberg EL; Phillips GD; Holmen J; Stoddard G; Orme J
    Chest; 2013 May; 143(5):1226-1234. PubMed ID: 23238456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic variability and mortality in critically ill patients: the impact of diabetes.
    Krinsley JS
    J Diabetes Sci Technol; 2009 Nov; 3(6):1292-301. PubMed ID: 20144383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study.
    Krinsley JS; Egi M; Kiss A; Devendra AN; Schuetz P; Maurer PM; Schultz MJ; van Hooijdonk RT; Kiyoshi M; Mackenzie IM; Annane D; Stow P; Nasraway SA; Holewinski S; Holzinger U; Preiser JC; Vincent JL; Bellomo R
    Crit Care; 2013 Mar; 17(2):R37. PubMed ID: 23452622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults.
    Krinsley JS; Preiser JC
    Crit Care; 2015 Apr; 19(1):179. PubMed ID: 25927986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of tight glucose control for critically ill surgical patients: a process improvement analysis.
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    Surg Infect (Larchmt); 2009 Dec; 10(6):523-31. PubMed ID: 20001333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients.
    der Voort PH; Feenstra RA; Bakker AJ; Heide L; Boerma EC; van der Horst IC
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):141-5. PubMed ID: 16430711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patients.
    Doola R; Greer RM; Hurford R; Flatley C; Forbes JM; Todd AS; Joyce CJ; Sturgess DJ
    Clin Nutr; 2019 Aug; 38(4):1707-1712. PubMed ID: 30170779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study.
    Galiatsatos P; Gibson BR; Rabiee A; Carlson O; Egan JM; Shannon RP; Andersen DK; Elahi D
    Crit Care Med; 2014 Mar; 42(3):638-45. PubMed ID: 24247476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild hypoglycemia is independently associated with increased mortality in the critically ill.
    Krinsley JS; Schultz MJ; Spronk PE; Harmsen RE; van Braam Houckgeest F; van der Sluijs JP; Mélot C; Preiser JC
    Crit Care; 2011 Jul; 15(4):R173. PubMed ID: 21787410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic variability and glucose complexity in critically ill patients: a retrospective analysis of continuous glucose monitoring data.
    Brunner R; Adelsmayr G; Herkner H; Madl C; Holzinger U
    Crit Care; 2012 Oct; 16(5):R175. PubMed ID: 23031322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose control and mortality in critically ill patients.
    Finney SJ; Zekveld C; Elia A; Evans TW
    JAMA; 2003 Oct; 290(15):2041-7. PubMed ID: 14559958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition From Intravenous to Subcutaneous Insulin in Critically Ill Adults.
    Doolin MK; Walroth TA; Harris SA; Whitten JA; Fritschle-Hilliard AC
    J Diabetes Sci Technol; 2016 Jul; 10(4):932-8. PubMed ID: 26908569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a hypoglycemia treatment protocol on glycemic variability in critically ill patients.
    Arnold P; Paxton RA; McNorton K; Szpunar S; Edwin SB
    J Intensive Care Med; 2015 Mar; 30(3):156-60. PubMed ID: 24277155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support.
    Dickerson RN; Hamilton LA; Connor KA; Maish GO; Croce MA; Minard G; Brown RO
    Nutrition; 2011; 27(7-8):766-72. PubMed ID: 20971617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of a graduated intravenous insulin infusion protocol in critically ill trauma patients receiving specialized nutritional support.
    Dickerson RN; Swiggart CE; Morgan LM; Maish GO; Croce MA; Minard G; Brown RO
    Nutrition; 2008 Jun; 24(6):536-45. PubMed ID: 18403182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of glycemic variability and hypoglycemia on adverse hospital outcomes in non-critically ill patients.
    Kim Y; Rajan KB; Sims SA; Wroblewski KE; Reutrakul S
    Diabetes Res Clin Pract; 2014 Mar; 103(3):437-43. PubMed ID: 24456994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower Glucose Target Is Associated With Improved 30-Day Mortality in Cardiac and Cardiothoracic Patients.
    Hersh AM; Hirshberg EL; Wilson EL; Orme JF; Morris AH; Lanspa MJ
    Chest; 2018 Nov; 154(5):1044-1051. PubMed ID: 29705217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.